Advertisement
Screener

TSCAN THERAPEUTICS, INC. (TCRX) Cash Flow Breakdown

TSCAN THERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where TSCAN THERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $135.32M went out.
  • Fiscal year ended 2025-12-31: from investing, $109.37M came in.
  • Fiscal year ended 2025-12-31: from financing, $336.00K went out.
  • Fiscal year ended 2025-12-31: change in cash, $26.28M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew debtCommercial paperNew shares soldNot split outChange in cash
2025-12-31-$135.32M$109.37M$264.00K*-$26.28M
2024-12-31-$110.82M-$52.61M$32.46M$33.13M$143.18M*$45.33M
2023-12-31-$61.36M-$60.76M$42.41M$93.03M*$13.33M
2022-12-31-$66.50M-$4.22M$29.35M$133.00K-$41.37M
2021-12-31-$48.68M-$9.94M$291.00K$189.38M*$131.05M
2020-12-31-$3.02M-$4.24M$288.00K-$6.97M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew debtNew shares soldNot split outChange in cash
2026-06-30-$27.54M*-$465.00K*
2026-03-31-$24.28M-$70.00K-$24.35M
2025-12-31-$32.00M*$14.83M*$73.00K*
2025-09-30-$32.46M*$32.58M*$0.00*
2025-06-30-$33.27M*$48.44M*
2025-03-31-$37.59M$13.53M-$525.00K*-$24.58M
2024-12-31-$27.41M*$27.29M*$0.00*$45.69M*
2024-09-30-$27.92M*-$82.35M*$0.00*$1.23M*
2024-06-30-$26.23M*-$33.72M*$184.00K*$161.40M*
2024-03-31-$29.27M$36.16M$258.00K$7.15M
2023-12-31-$23.77M*$1.91M*$0.00*
2023-09-30$8.02M*-$61.41M*-$186.00K*
2023-06-30-$22.02M*-$420.00K*
2023-03-31-$23.59M-$838.00K-$24.43M
2022-12-31-$16.01M*-$1.38M*$0.00*$9.00K*
2022-09-30-$17.00M*-$424.00K*$5.00K*$29.12M*
2022-06-30-$13.37M*-$1.89M*$31.00K*
2022-03-31-$20.12M-$531.00K$88.00K-$20.57M
2021-12-31-$14.38M*-$2.21M*$120.00K*
2021-09-30-$13.64M*-$853.00K*$1.00K*$90.61M*
2021-06-30-$10.70M*-$3.92M*$62.00K*-$748.00K*
2021-03-31-$9.96M-$2.96M$108.00K$99.52M*$86.71M
2020-12-31-$7.35M*-$1.39M*$40.00K*
2020-09-30-$5.79M*-$1.34M*$1.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
AIM ImmunoTech Inc. (AIM)United States$0.006B
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
IN8BIO, INC. (INAB)United States$0.012B-0.76
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B